| Literature DB >> 34161188 |
Mingzhao Wang1,2, Juanying Xie2, Shengquan Xu1.
Abstract
N6-methyladenosine (m6A) plays an important role in various biological processes. Identifying m6A site is a key step in exploring its biological functions. One of the biggest challenges in identifying m6A sites is how to extract features comprising rich categorical information to distinguish m6A and non-m6A sites. To address this challenge, we propose bidirectional dinucleotide and trinucleotide position-specific propensities, respectively, in this paper. Based on this, we propose two feature-encoding algorithms: Position-Specific Propensities and Pointwise Mutual Information (PSP-PMI) and Position-Specific Propensities and Pointwise Joint Mutual Information (PSP-PJMI). PSP-PMI is based on the bidirectional dinucleotide propensity and the pointwise mutual information, while PSP-PJMI is based on the bidirectional trinucleotide position-specific propensity and the proposed pointwise joint mutual information in this paper. We introduce parameters α and β in PSP-PMI and PSP-PJMI, respectively, to represent the distance from the nucleotide to its forward or backward adjacent nucleotide or dinucleotide, so as to extract features containing local and global classification information. Finally, we propose the M6A-BiNP predictor based on PSP-PMI or PSP-PJMI and SVM classifier. The 10-fold cross-validation experimental results on the benchmark datasets of non-single-base resolution and single-base resolution demonstrate that PSP-PMI and PSP-PJMI can extract features with strong capabilities to identify m6A and non-m6A sites. The M6A-BiNP predictor based on our proposed feature encoding algorithm PSP-PJMI is better than the state-of-the-art predictors, and it is so far the best model to identify m6A and non-m6A sites.Entities:
Keywords: N6-methyladenosine (m6A); feature representation; nucleotide position-specific propensities; pointwise joint mutual information; predictive model
Mesh:
Substances:
Year: 2021 PMID: 34161188 PMCID: PMC8632114 DOI: 10.1080/15476286.2021.1930729
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652
The detailed information of the non-single-base resolution benchmark datasets
| Species | # positive samples | # negative samples | #Total samples | Sequence length ( |
|---|---|---|---|---|
| 394 | 394 | 788 | 25 | |
| 725 | 725 | 1450 | 41 | |
| 1130 | 1130 | 2260 | 41 | |
| 1307 | 1307 | 2614 | 51 |
The detailed information of the single-base resolution benchmark datasets
| Species | Tissues | Name | Training dataset | Independent dataset | ||||
|---|---|---|---|---|---|---|---|---|
| # positive | # negative | # positive | # negative | Identification method | Sequence length ( | |||
| Rat | Brain | RB | 2352 | 2352 | 2351 | 2351 | m6A-REF-seq | 41 |
| Kidney | RK | 3433 | 3433 | 3432 | 3432 | |||
| Liver | RL | 1762 | 1762 | 1762 | 1762 | |||
| Mouse | Brain | MB | 8025 | 8025 | 8025 | 8025 | ||
| Heart | MH | 2201 | 2201 | 2200 | 2200 | |||
| Kidney | MK | 3953 | 3953 | 3952 | 3952 | |||
| Liver | ML | 4133 | 4133 | 4133 | 4133 | |||
| Testis | MT | 4707 | 4707 | 4706 | 4706 | |||
| Human | Brain | HB | 4605 | 4605 | 4604 | 4604 | ||
| Kidney | HK | 4574 | 4574 | 4573 | 4573 | |||
| Liver | HL | 2634 | 2634 | 2634 | 2634 | |||
| – | Human51 | 8366 | 8366 | – | – | miCLIP | 51 | |
Figure 1.The bidirectional dinucleotide position-specific propensity. (a) for , (b) for
Figure 2.The bidirectional trinucleotide position-specific propensity. (a) for , (b) for
Figure 3.Framework of our M6A-BiNP predictor
Figure 4.The nucleotide position-specific propensity. (a) Arabidopsis thaliana, (b) Musculus, (c) Homo sapiens and (d) Saccharomyces cerevisiae. The nucleotide A at position 0 is m6A site in positive sequence and non-m6A site in negative sequence. The nucleotide symbols in the upper of a picture indicate that the corresponding nucleotide is enriched in positive dataset. The nucleotide symbols in the lower indicate that the corresponding nucleotide is depleted in positive dataset. The nucleotide symbols in the middle indicate that the corresponding nucleotide is the consensus motif in both datasets
Figure 5.The performance of SVM built on features encoded by (a) PSP-PMI and (b) PSP-PJMI via varying parameters and on Saccharomyces cerevisiae. The bar chart represents the performance of the SVM built on features corresponding to different and . The line chart represents the performance of the SVM built on concatenating features
Performance comparison between our PSP-PMI, PSP-PJMI and other seven feature representation algorithms on four non-single-base resolution datasets
| Algorithms | Acc | Sn | Sp | MCC | Acc | Sn | Sp | MCC |
|---|---|---|---|---|---|---|---|---|
| PSP-PMI | 0.830 | 0.825 | 0.835 | 0.661 | 0.901 | 0.909 | 0.894 | 0.804 |
| PSP-PJMI | 0.961− | 0.960− | 0.962− | 0.924− | 0.994− | 0.996− | 0.992− | 0.988− |
| PSNP | 0.840= | 0.683+ | 0.998− | 0.717= | 0.856+ | 0.712+ | 1.000− | 0.745+ |
| PSDP | 0.843= | 0.685+ | 1.000− | 0.723= | 0.885= | 0.771+ | 1.000− | 0.793= |
| KNF | 0.787+ | 0.622+ | 0.952− | 0.609= | 0.732+ | 0.657+ | 0.808+ | 0.472+ |
| KSNPF | 0.666+ | 0.617+ | 0.715+ | 0.334+ | 0.663+ | 0.648+ | 0.678+ | 0.329+ |
| NPPS | 0.925− | 0.891− | 0.959− | 0.854− | 0.918= | 0.855= | 0.981− | 0.844= |
| PBE | 0.840= | 0.683+ | 0.998− | 0.717= | 0.885= | 0.771+ | 1.000− | 0.793= |
| NCPNC | 0.843= | 0.685+ | 1.000− | 0.723= | 0.881= | 0.763+ | 1.000− | 0.786= |
| +/ = /- | 2/4/2 | 6/0/2 | 1/0/7 | 1/5/2 | 3/4/1 | 6/1/1 | 2/0/6 | 3/4/1 |
| | ||||||||
| PSP-PMI | 0.849 | 0.858 | 0.841 | 0.700 | 0.905 | 0.916 | 0.894 | 0.810 |
| PSP-PJMI | 0.986− | 0.982− | 0.989− | 0.972− | 0.995− | 0.996− | 0.994− | 0.990− |
| PSNP | 0.902− | 0.804+ | 1.000− | 0.821− | 0.747+ | 0.751+ | 0.743+ | 0.495+ |
| PSDP | 0.903− | 0.806+ | 1.000− | 0.822− | 0.766+ | 0.764+ | 0.769+ | 0.534+ |
| KNF | 0.797+ | 0.695+ | 0.899− | 0.607+ | 0.692+ | 0.741+ | 0.643+ | 0.387+ |
| KSNPF | 0.680+ | 0.612+ | 0.749+ | 0.365+ | 0.651+ | 0.712+ | 0.591+ | 0.307+ |
| NPPS | 0.908− | 0.817+ | 0.999− | 0.830− | 0.874+ | 0.884+ | 0.864= | 0.749+ |
| PBE | 0.908− | 0.817+ | 1.000− | 0.831− | 0.727+ | 0.727+ | 0.728+ | 0.456+ |
| NCPNC | 0.909− | 0.818+ | 1.000− | 0.832− | 0.731+ | 0.735+ | 0.726+ | 0.463+ |
| +/ = /- | 2/0/6 | 7/0/1 | 1/0/7 | 2/0/6 | 7/0/1 | 7/0/1 | 6/1/1 | 7/0/1 |
Figure 6.ROC and P-R curves of nine feature representation algorithms on four datasets. (a) – (d) AUROC, (e) – (h) AUPRC
Performance comparison between our M6A-BiNP and the state-of-the-art predictors on four species m6A benchmark datasets
| Datasets | Predictors | Classifiers | Experiment methods | Evaluation criteria | |||||
|---|---|---|---|---|---|---|---|---|---|
| Acc | Sn | Sp | MCC | AUROC | AUPRC | ||||
| M6ATH [ | SVM | jackknife | 0.844 | 0.688 | 0.720 | 0.846 | 0.870 | ||
| RAM-NPPS [ | SVM | jackknife | 0.895 | 0.873 | 0.916 | 0.790 | – | – | |
| m6A-word2vec [ | CNN | 10-fold cross-validation | 0.905 | 0.950 | 0.859 | 0.810 | 0.928 | – | |
| M6A-BiNP | SVM (PSP-PMI) | 10-fold cross-validation | 0.830 | 0.825 | 0.835 | 0.661 | 0.897 | 0.904 | |
| SVM (PSP-PJMI) | 10-fold cross-validation | 0.962 | |||||||
| iN6-Methyl [ | CNN | 10-fold cross-validation | 0.895 | 0.789 | 0.808 | 0.913 | – | ||
| M6AMRFS [ | XGBoost | 10-fold cross-validation | 0.793 | 0.828 | 0.758 | 0.588 | – | – | |
| MethyRNA [ | SVM | jackknife | 0.884 | 0.778 | – | – | – | ||
| iMRM [ | XGboost | jackknife | 0.890 | 0.783 | 0.996 | 0.779 | 0.820 | – | |
| m6A-NeuralTool [ | CNN | 10-fold cross-validation | 0.958 | 0.915 | 0.912 | 0.960 | – | ||
| pm6A-CNN [ | CNN | 10-fold cross-validation | 0.938 | 0.904 | 0.972 | 0.880 | 0.970 | – | |
| Second order-MM [ | Markov model | 10-fold cross-validation | 0.883 | 0.875 | 0.889 | 0.775 | – | – | |
| SRAMP [ | RF | 10-fold cross-validation | 0.889 | 0.778 | 0.798 | – | – | ||
| M6A-BiNP | SVM (PSP-PMI) | 10-fold cross-validation | 0.901 | 0.909 | 0.894 | 0.804 | 0.962 | 0.962 | |
| SVM (PSP-PJMI) | 10-fold cross-validation | 0.992 | |||||||
| M6AMRFS [ | XGBoost | 10-fold cross-validation | 0.910 | 0.820 | 0.834 | – | – | ||
| MethyRNA [ | SVM | jackknife | 0.904 | 0.817 | 0.991 | – | – | – | |
| iRNA-Methyl [ | SVM | jackknife | 0.672 | 0.575 | 0.769 | – | – | – | |
| iN6-Methyl [ | CNN | 10-fold cross-validation | 0.911 | 0.821 | 0.835 | 0.903 | – | ||
| iMRM [ | XGboost | jackknife | 0.910 | 0.825 | 0.996 | 0.820 | 0.940 | – | |
| m6A-NeuralTool [ | CNN | 10-fold cross-validation | 0.960 | 0.920 | 0.882 | 0.950 | – | ||
| pm6A-CNN [ | CNN | 10-fold cross-validation | 0.936 | 0.886 | 0.986 | 0.878 | 0.960 | – | |
| m6A-word2vec [ | CNN | 10-fold cross-validation | 0.927 | 0.981 | 0.882 | 0.850 | 0.951 | – | |
| Second order-MM [ | Markov model | 10-fold cross-validation | 0.906 | 0.865 | 0.947 | 0.814 | – | – | |
| SRAMP [ | RF | 10-fold cross-validation | 0.898 | 0.797 | 0.814 | – | – | ||
| M6A-BiNP | SVM (PSP-PMI) | 10-fold cross-validation | 0.849 | 0.858 | 0.841 | 0.700 | 0.928 | 0.928 | |
| SVM (PSP-PJMI) | 10-fold cross-validation | 0.989 | |||||||
| M6APredict-EL [ | EL | 10-fold cross-validation | 0.808 | 0.807 | 0.810 | 0.620 | 0.902 | 0.901 | |
| RAM-NPPS [ | SVM | 10-fold cross-validation | 0.799 | 0.790 | 0.808 | 0.598 | – | – | |
| M6AMRFS [ | XGBoost | 10-fold cross-validation | 0.743 | 0.752 | 0.733 | 0.485 | – | – | |
| M6A-HPCS [ | SVM | jackknife | 0.724 | 0.774 | 0.674 | 0.450 | 0.782 | – | |
| iRNA-Methyl [ | SVM | jackknife | 0.656 | 0.706 | 0.606 | 0.290 | 0.705 | – | |
| pRNAm-PC [ | SVM | jackknife | 0.697 | 0.697 | 0.698 | 0.400 | 0.763 | – | |
| RAM-ESVM [ | SVM | jackknife | 0.748 | 0.789 | 0.778 | 0.570 | – | – | |
| BERMP [ | DL and RF | independent | 0.713 | 0.730 | 0.696 | 0.430 | 0.800 | – | |
| iMethyl-STTNC [ | SVM | 10-fold cross-validation | 0.698 | 0.703 | 0.682 | 0.380 | – | – | |
| iN6-Methyl [ | CNN | 10-fold cross-validation | 0.754 | 0.762 | 0.746 | 0.508 | 0.803 | – | |
| M6A-PXGB [ | XGBoost | 10-fold cross-validation | 0.771 | 0.764 | 0.760 | 0.535 | 0.839 | – | |
| DeepM6APred [ | SVM | 10-fold cross-validation | 0.805 | 0.795 | 0.815 | 0.610 | – | – | |
| iMRM [ | XGboost | jackknife | 0.778 | 0.770 | 0.785 | 0.555 | 0.85 | – | |
| m6A-NeuralTool [ | CNN | 10-fold cross-validation | 0.790 | 0.783 | 0.796 | 0.614 | – | – | |
| pm6A-CNN [ | CNN | 10-fold cross-validation | 0.850 | 0.846 | 0.855 | 0.703 | 0.920 | – | |
| m6A-word2vec [ | CNN | 10-fold cross-validation | 0.832 | 0.865 | 0.799 | 0.660 | 0.901 | – | |
| iMethyl-deep [ | CNN | 10-fold cross-validation | 0.892 | 0.885 | 0.899 | 0.780 | 0.931 | – | |
| DNN-m6A [ | DNN | 10-fold cross-validation | 0.785 | 0.787 | 0.783 | 0.571 | – | – | |
| M6A-BiNP | SVM (PSP-PMI) | 10-fold cross-validation | 0.905 | 0.916 | 0.894 | 0.810 | 0.968 | 0.967 | |
| SVM (PSP-PJMI) | 10-fold cross-validation | ||||||||
Comparison of M6A-BiNP models and RAM-NPPS on Human51 dataset
| Model | Acc | Sn | Sp | MCC | AUROC | AUPRC |
|---|---|---|---|---|---|---|
| M6A-BiNP (PSP-PMI) | 0.711 | 0.733 | 0.689 | 0.423 | 0.782 | 0.772 |
| M6A-BiNP (PSP-PJMI) | ||||||
| RAM-NPPS | 0.722 | 0.733 | 0.710 | 0.443 | 0.794 | 0.785 |
Performance comparison of our M6A-BiNP with iRNA-m6A, im6A-TS-CNN and DNN-m6A models on the training datasets
| Species | Tissues | Name | Methods | Acc | Sn | Sp | MCC | AUROC |
|---|---|---|---|---|---|---|---|---|
| Human | Brain | HB | M6A-BiNP (PSP-PMI) | 0.720 | 0.711 | 0.729 | 0.440 | 0.793 |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.713 | 0.748 | 0.662 | 0.410 | 0.776 | |||
| im6A-TS-CNN | 0.725 | 0.754 | 0.697 | 0.452 | 0.803 | |||
| DNN-m6A | 0.738 | 0.785 | 0.691 | 0.480 | 0.817 | |||
| Kidney | HK | M6A-BiNP (PSP-PMI) | 0.746 | 0.755 | 0.738 | 0.493 | 0.832 | |
| M6A-BiNP (PSP-PJMI) | 0.809 | |||||||
| iRNA-m6A | 0.790 | 0.809 | 0.763 | 0.570 | 0.863 | |||
| im6A-TS-CNN | 0.800 | 0.817 | 0.783 | 0.601 | 0.878 | |||
| DNN-m6A | 0.805 | 0.774 | 0.610 | 0.884 | ||||
| Liver | HL | M6A-BiNP (PSP-PMI) | 0.775 | 0.769 | 0.781 | 0.550 | 0.856 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.801 | 0.813 | 0.781 | 0.590 | 0.874 | |||
| im6A-TS-CNN | 0.802 | 0.797 | 0.799 | 0.599 | 0.881 | |||
| DNN-m6A | 0.813 | 0.822 | 0.804 | 0.630 | 0.891 | |||
| Mouse | Brain | MB | M6A-BiNP (PSP-PMI) | 0.732 | 0.744 | 0.720 | 0.464 | 0.818 |
| M6A-BiNP (PSP-PJMI) | 0.772 | 0.768 | 0.544 | 0.858 | ||||
| iRNA-m6A | 0.788 | 0.793 | 0.769 | 0.580 | 0.870 | |||
| im6A-TS-CNN | 0.787 | 0.815 | 0.759 | 0.575 | 0.871 | |||
| DNN-m6A | 0.770 | |||||||
| Heart | MH | M6A-BiNP (PSP-PMI) | 0.794 | 0.807 | 0.780 | 0.588 | 0.880 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.728 | 0.752 | 0.690 | 0.440 | 0.795 | |||
| im6A-TS-CNN | 0.730 | 0.784 | 0.676 | 0.463 | 0.812 | |||
| DNN-m6A | 0.762 | 0.775 | 0.748 | 0.520 | 0.844 | |||
| Kidney | MK | M6A-BiNP (PSP-PMI) | 0.775 | 0.795 | 0.754 | 0.550 | 0.859 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.800 | 0.826 | 0.773 | 0.600 | 0.873 | |||
| im6A-TS-CNN | 0.805 | 0.799 | 0.810 | 0.609 | 0.884 | |||
| DNN-m6A | 0.820 | 0.832 | 0.807 | 0.640 | 0.895 | |||
| Liver | ML | M6A-BiNP (PSP-PMI) | 0.728 | 0.755 | 0.701 | 0.456 | 0.813 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.706 | 0.749 | 0.656 | 0.410 | 0.774 | |||
| im6A-TS-CNN | 0.713 | 0.724 | 0.702 | 0.429 | 0.795 | |||
| DNN-m6A | 0.736 | 0.776 | 0.696 | 0.470 | 0.814 | |||
| Testis | MT | M6A-BiNP (PSP-PMI) | 0.743 | 0.777 | 0.709 | 0.487 | 0.824 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.744 | 0.781 | 0.700 | 0.480 | 0.816 | |||
| im6A-TS-CNN | 0.754 | 0.752 | 0.756 | 0.509 | 0.838 | |||
| DNN-m6A | 0.766 | 0.810 | 0.723 | 0.530 | 0.849 | |||
| Rat | Brain | RB | M6A-BiNP (PSP-PMI) | 0.785 | 0.784 | 0.786 | 0.570 | 0.869 |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.760 | 0.770 | 0.735 | 0.500 | 0.828 | |||
| im6A-TS-CNN | 0.766 | 0.790 | 0.742 | 0.538 | 0.847 | |||
| DNN-m6A | 0.783 | 0.791 | 0.775 | 0.570 | 0.868 | |||
| Kidney | RK | M6A-BiNP (PSP-PMI) | 0.781 | 0.792 | 0.771 | 0.563 | 0.868 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.818 | 0.825 | 0.801 | 0.630 | 0.888 | |||
| im6A-TS-CNN | 0.825 | 0.842 | 0.808 | 0.650 | 0.902 | |||
| DNN-m6A | 0.834 | 0.843 | 0.825 | 0.670 | 0.910 | |||
| Liver | RL | M6A-BiNP (PSP-PMI) | 0.826 | 0.826 | 0.826 | 0.653 | 0.912 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.809 | 0.831 | 0.763 | 0.600 | 0.877 | |||
| im6A-TS-CNN | 0.806 | 0.816 | 0.796 | 0.613 | 0.883 | |||
| DNN-m6A | 0.826 | 0.842 | 0.811 | 0.650 | 0.899 |
Performance comparison of our M6A-BiNP with iRNA-m6A, im6A-TS-CNN and DNN-m6A models on the independent datasets
| Species | Tissues | Name | Methods | Acc | Sn | Sp | MCC | AUROC |
|---|---|---|---|---|---|---|---|---|
| Human | Brain | HB | M6A-BiNP (PSP-PMI) | 0.708 | 0.746 | 0.670 | 0.417 | 0.779 |
| M6A-BiNP (PSP-PJMI) | 0.580 | |||||||
| iRNA-m6A | 0.711 | 0.695 | 0.730 | 0.420 | 0.785 | |||
| im6A-TS-CNN | 0.727 | 0.702 | 0.454 | 0.806 | ||||
| DNN-m6A | 0.733 | 0.750 | 0.715 | 0.470 | 0.815 | |||
| Kidney | HK | M6A-BiNP (PSP-PMI) | 0.694 | 0.883 | 0.506 | 0.419 | 0.807 | |
| M6A-BiNP (PSP-PJMI) | 0.682 | 0.400 | 0.441 | |||||
| iRNA-m6A | 0.778 | 0.771 | 0.784 | 0.560 | 0.857 | |||
| im6A-TS-CNN | 0.792 | 0.800 | 0.585 | 0.873 | ||||
| DNN-m6A | 0.832 | 0.766 | 0.878 | |||||
| Liver | HL | M6A-BiNP (PSP-PMI) | 0.739 | 0.650 | 0.487 | 0.824 | ||
| M6A-BiNP (PSP-PJMI) | 0.805 | |||||||
| iRNA-m6A | 0.790 | 0.782 | 0.799 | 0.580 | 0.868 | |||
| im6A-TS-CNN | 0.799 | 0.848 | 0.750 | 0.601 | 0.881 | |||
| DNN-m6A | 0.810 | 0.818 | 0.801 | 0.620 | 0.885 | |||
| Mouse | Brain | MB | M6A-BiNP (PSP-PMI) | 0.719 | 0.596 | 0.451 | 0.815 | |
| M6A-BiNP (PSP-PJMI) | 0.756 | 0.838 | 0.674 | 0.518 | 0.849 | |||
| iRNA-m6A | 0.783 | 0.772 | 0.794 | 0.570 | 0.861 | |||
| im6A-TS-CNN | 0.785 | 0.707 | 0.872 | |||||
| DNN-m6A | 0.751 | 0.821 | 0.570 | |||||
| Heart | MH | M6A-BiNP (PSP-PMI) | 0.774 | 0.651 | 0.898 | 0.566 | 0.881 | |
| M6A-BiNP (PSP-PJMI) | 0.681 | |||||||
| iRNA-m6A | 0.713 | 0.705 | 0.721 | 0.430 | 0.788 | |||
| im6A-TS-CNN | 0.736 | 0.758 | 0.714 | 0.472 | 0.816 | |||
| DNN-m6A | 0.751 | 0.730 | 0.500 | 0.834 | ||||
| Kidney | MK | M6A-BiNP (PSP-PMI) | 0.765 | 0.707 | 0.533 | 0.854 | ||
| M6A-BiNP (PSP-PJMI) | 0.758 | |||||||
| iRNA-m6A | 0.793 | 0.784 | 0.803 | 0.590 | 0.870 | |||
| im6A-TS-CNN | 0.808 | 0.805 | 0.810 | 0.615 | 0.886 | |||
| DNN-m6A | 0.809 | 0.812 | 0.806 | 0.620 | 0.889 | |||
| Liver | ML | M6A-BiNP (PSP-PMI) | 0.735 | 0.676 | 0.795 | 0.474 | 0.817 | |
| M6A-BiNP (PSP-PJMI) | 0.699 | |||||||
| iRNA-m6A | 0.688 | 0.678 | 0.699 | 0.380 | 0.762 | |||
| im6A-TS-CNN | 0.716 | 0.756 | 0.676 | 0.433 | 0.793 | |||
| DNN-m6A | 0.730 | 0.695 | 0.460 | 0.808 | ||||
| Testis | MT | M6A-BiNP (PSP-PMI) | 0.746 | 0.836 | 0.657 | 0.501 | 0.832 | |
| M6A-BiNP (PSP-PJMI) | ||||||||
| iRNA-m6A | 0.735 | 0.722 | 0.751 | 0.470 | 0.818 | |||
| im6A-TS-CNN | 0.762 | 0.835 | 0.689 | 0.529 | 0.847 | |||
| DNN-m6A | 0.771 | 0.801 | 0.742 | 0.540 | 0.854 | |||
| Rat | Brain | RB | M6A-BiNP (PSP-PMI) | 0.766 | 0.612 | 0.559 | 0.883 | |
| M6A-BiNP (PSP-PJMI) | 0.744 | |||||||
| iRNA-m6A | 0.751 | 0.739 | 0.765 | 0.500 | 0.827 | |||
| im6A-TS-CNN | 0.770 | 0.781 | 0.758 | 0.539 | 0.852 | |||
| DNN-m6A | 0.780 | 0.777 | 0.783 | 0.560 | 0.862 | |||
| Kidney | RK | M6A-BiNP (PSP-PMI) | 0.777 | 0.786 | 0.767 | 0.553 | 0.861 | |
| M6A-BiNP (PSP-PJMI) | 0.771 | 0.575 | 0.588 | |||||
| iRNA-m6A | 0.814 | 0.802 | 0.630 | 0.897 | ||||
| im6A-TS-CNN | 0.827 | 0.849 | 0.806 | 0.655 | 0.908 | |||
| DNN-m6A | 0.853 | 0.807 | 0.911 | |||||
| Liver | RL | M6A-BiNP (PSP-PMI) | 0.829 | 0.857 | 0.801 | 0.659 | 0.912 | |
| M6A-BiNP (PSP-PJMI) | 0.786 | |||||||
| iRNA-m6A | 0.799 | 0.777 | 0.600 | 0.876 | ||||
| im6A-TS-CNN | 0.802 | 0.845 | 0.759 | 0.607 | 0.885 | |||
| DNN-m6A | 0.816 | 0.828 | 0.805 | 0.630 | 0.896 |